speb/financial-data huggingface dataset:
CVSA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 37057000.00
CVSA income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.67
CVSA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 61832000.00
CVSA income_statement (quarterly, 2025-09-30) — EBIT: 86392000.00
CVSA income_statement (quarterly, 2025-09-30) — EBITDA: 106709000.00
CVSA cash_flow (quarterly, 2025-09-30) — End Cash Position: 266185000.00
CVSA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -49505000.00
CVSA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 114526000.00
CVSA cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -680000.00
CVSA cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 2000.00
CVSA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 680000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 175734000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Goodwill: 961262000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1723931000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 249458000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 797912000.00
CVSA income_statement (quarterly, 2025-09-30) — Gross Profit: 261521000.00
CVSA income_statement (quarterly, 2025-09-30) — Interest Expense: 9519000.00
CVSA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 9519000.00
CVSA income_statement (quarterly, 2025-09-30) — Interest Income: 1806000.00
CVSA income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1806000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2010776000.00
CVSA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -16023000.00
CVSA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CVSA balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 31776000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Leases: 121469000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 188406000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 553152000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 741558000.00
CVSA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CVSA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
CVSA balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 223015000.00
CVSA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -7595000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Net Debt: 288461000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Income: 61832000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 61832000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 61062000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 770000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 61832000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 61062000.00
CVSA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 61062000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 61832000.00
CVSA income_statement (quarterly, 2025-09-30) — Net Interest Income: -9284000.00
CVSA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
CVSA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CVSA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
CVSA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -9284000.00
CVSA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -42452000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Net PPE: 447119000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -266307000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 0.00
CVSA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 53313000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 0.00
CVSA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 53313000.00
CVSA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 106339000.00
CVSA income_statement (quarterly, 2025-09-30) — Normalized Income: 60768220.00
CVSA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 130549000.00
CVSA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -678000.00
CVSA income_statement (quarterly, 2025-09-30) — Operating Income: 85787000.00
CVSA income_statement (quarterly, 2025-09-30) — Operating Revenue: 460098000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 36324000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 106195000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2227000.00
CVSA income_statement (quarterly, 2025-09-30) — Other Gand A: 175734000.00
CVSA income_statement (quarterly, 2025-09-30) — Other Income Expense: 370000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 762669000.00
CVSA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1145000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 129196000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 38352000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Other Properties: 189762000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Payables: 104576000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 219357000.00
CVSA income_statement (quarterly, 2025-09-30) — Pretax Income: 76873000.00
CVSA cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 542000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CVSA cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 14883000.00
CVSA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -100000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Receivables: 194837000.00
CVSA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 200767000.00
CVSA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 20317000.00
CVSA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
CVSA cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -7595000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 1494000.00
CVSA income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 310000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2839406000.00
CVSA cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 100000.00
CVSA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 175734000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Share Issued: 84657000.00
CVSA income_statement (quarterly, 2025-09-30) — Special Income Charges: -310000.00
CVSA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 8293000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1457624000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -266307000.00
CVSA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 76220.00
CVSA income_statement (quarterly, 2025-09-30) — Tax Provision: 15811000.00
CVSA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CVSA balance_sheet (quarterly, 2025-09-30) — Total Assets: 2867463000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2010776000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Total Debt: 775950000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1457624000.00
CVSA income_statement (quarterly, 2025-09-30) — Total Expenses: 376501000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1409839000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2300246000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 833223000.00
CVSA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 85477000.00
CVSA income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 1571000.00
CVSA income_statement (quarterly, 2025-09-30) — Total Unusual Items: 370000.00
CVSA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 370000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 48333000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 2053424000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Working Capital: -9399000.00
CVSA income_statement (quarterly, 2025-12-31) — +Operating Expense: 182791000.00
CVSA income_statement (quarterly, 2025-12-31) — +Total Revenue: 503385000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 103103000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 162848000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -361243000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 686587000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -55020000.00
CVSA cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 2805000.00
CVSA cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 2805000.00
CVSA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 35725000.00
CVSA income_statement (quarterly, 2025-12-31) — Basic EPS: 2.14
CVSA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 266185000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 203755000.00
CVSA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -14624000.00
CVSA cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -14624000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 225270000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 847000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 56281000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 56281000.00
CVSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -217666000.00
CVSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -19623000.00
CVSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 29484000.00
CVSA cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: 260000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2856000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 6195000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -2319000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -4444000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -141164000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Payable: -2856000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3339000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 26412000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 15965000.00
CVSA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -102211000.00
CVSA cash_flow (quarterly, 2025-12-31) — Changes In Cash: -207545000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Common Stock: 847000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1378796000.00
CVSA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -164767000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 33200000.00
CVSA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 205425000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 125436000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Current Assets: 302982000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 33917000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 33917000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 180429000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 180429000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 442885000.00
CVSA cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 3502000.00
CVSA cash_flow (quarterly, 2025-12-31) — Deferred Tax: 3502000.00
CVSA cash_flow (quarterly, 2025-12-31) — Depreciation: 18149000.00
CVSA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 20954000.00
CVSA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 20954000.00
CVSA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 36230000.00
CVSA income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.11
CVSA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 76376000.00
CVSA income_statement (quarterly, 2025-12-31) — EBIT: 111518000.00
CVSA income_statement (quarterly, 2025-12-31) — EBITDA: 132472000.00
CVSA cash_flow (quarterly, 2025-12-31) — End Cash Position: 58640000.00
CVSA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -217666000.00
CVSA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 15120000.00
CVSA cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -130000.00
CVSA cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 2000.00
CVSA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 130000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Goodwill: 961262000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1721126000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 217868000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 816762000.00
CVSA income_statement (quarterly, 2025-12-31) — Gross Profit: 297960000.00
CVSA income_statement (quarterly, 2025-12-31) — Interest Expense: 9617000.00
CVSA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 9617000.00
CVSA income_statement (quarterly, 2025-12-31) — Interest Income: 1574000.00
CVSA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1574000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1883078000.00
CVSA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -19623000.00
CVSA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 227000000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 31776000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Leases: 128922000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 191353000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 504282000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 695635000.00
CVSA cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 227000000.00
CVSA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -277000000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 229626000.00
CVSA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -164767000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Net Debt: 448001000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Income: 76376000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 76376000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 76171000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 205000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 76376000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 76171000.00
CVSA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 76171000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 76376000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Interest Income: -9343000.00
CVSA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 1000.00
CVSA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -50000000.00
CVSA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -50000000.00
CVSA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -9343000.00
CVSA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -3303000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Net PPE: 455519000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -342330000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 0.00
CVSA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 56815000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
CVSA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 56815000.00
CVSA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 136397000.00
CVSA income_statement (quarterly, 2025-12-31) — Normalized Income: 79106900.00
CVSA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 29744000.00
CVSA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -128000.00
CVSA income_statement (quarterly, 2025-12-31) — Operating Income: 115169000.00
CVSA income_statement (quarterly, 2025-12-31) — Operating Revenue: 501754000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 34654000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 81494000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2227000.00
CVSA income_statement (quarterly, 2025-12-31) — Other Income Expense: -3925000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 759864000.00
CVSA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1409000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 135086000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 40582000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Other Properties: 189483000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Payables: 103103000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 228539000.00
CVSA income_statement (quarterly, 2025-12-31) — Pretax Income: 101901000.00
CVSA cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 404000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CVSA cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 16548000.00
CVSA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -2004000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Receivables: 162848000.00
CVSA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 205425000.00
CVSA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 20954000.00
CVSA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -277000000.00
CVSA cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -164767000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 2359000.00
CVSA income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 4055000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 2915782000.00
CVSA cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 2005000.00
CVSA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 182791000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Share Issued: 84740000.00
CVSA income_statement (quarterly, 2025-12-31) — Special Income Charges: -4055000.00
CVSA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 13239000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1378796000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -342330000.00
CVSA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -989100.00
CVSA income_statement (quarterly, 2025-12-31) — Tax Provision: 25730000.00
CVSA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
CVSA balance_sheet (quarterly, 2025-12-31) — Total Assets: 2614713000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1883078000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Total Debt: 729552000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1378796000.00
CVSA income_statement (quarterly, 2025-12-31) — Total Expenses: 388216000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1235917000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2311731000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 793032000.00
CVSA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 111114000.00
CVSA income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 1300000.00
CVSA income_statement (quarterly, 2025-12-31) — Total Unusual Items: -3925000.00
CVSA income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3925000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 50086000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 2222193000.00
CVSA balance_sheet (quarterly, 2025-12-31) — Working Capital: -139903000.00
CVSA income_statement (quarterly, 2026-03-31) — +Operating Expense: 184106000.00
CVSA income_statement (quarterly, 2026-03-31) — +Total Revenue: 487030000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 97261000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 175924000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -372451000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 696468000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -59560000.00
CVSA cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 2805000.00
CVSA cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 2805000.00
CVSA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 34283000.00
CVSA income_statement (quarterly, 2026-03-31) — Basic EPS: 1.21
CVSA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 58640000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 204915000.00
CVSA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -20235000.00
CVSA cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -20235000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 236825000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 847000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 146977000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 146977000.00
CVSA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -75732000.00
CVSA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -20235000.00
CVSA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 186301000.00
CVSA cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Operating Activities: -135000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -11129000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 19147000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -2956000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -6634000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 96476000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Payable: -11129000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 8018000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 2533000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -29546000.00
CVSA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 67891000.00
CVSA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -29546000.00
CVSA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 90199000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Common Stock: 847000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1364105000.00
CVSA cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -67504000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 32977000.00
CVSA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 210719000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 167939000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Assets: 403755000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 35230000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Debt: 3825000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 39055000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 276192000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 276192000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 580447000.00
CVSA cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 7403000.00
CVSA cash_flow (quarterly, 2026-03-31) — Deferred Tax: 7403000.00
CVSA cash_flow (quarterly, 2026-03-31) — Depreciation: 17970000.00
CVSA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 20775000.00
CVSA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 20775000.00
CVSA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 34782000.00
CVSA income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.20
CVSA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 41637000.00
CVSA income_statement (quarterly, 2026-03-31) — EBIT: 90026000.00
CVSA income_statement (quarterly, 2026-03-31) — EBITDA: 110801000.00
CVSA cash_flow (quarterly, 2026-03-31) — End Cash Position: 148839000.00
CVSA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -75732000.00
CVSA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 165931000.00
CVSA cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 249000.00
CVSA cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 601000.00
CVSA income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -249000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 184106000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Goodwill: 961262000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1718321000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 235484000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 850502000.00
CVSA income_statement (quarterly, 2026-03-31) — Gross Profit: 276311000.00
CVSA income_statement (quarterly, 2026-03-31) — Interest Expense: 12081000.00
CVSA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 12081000.00
CVSA income_statement (quarterly, 2026-03-31) — Interest Income: 481000.00
CVSA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 481000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1863574000.00
CVSA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -20235000.00
CVSA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 617450000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 31776000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Leases: 140951000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 201595000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 495644000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 697239000.00
CVSA cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 617450000.00
CVSA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -618283000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 238804000.00
CVSA cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
CVSA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -67504000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Net Debt: 352492000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Income: 41637000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 41637000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 57982000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -16345000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 41637000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 57982000.00
CVSA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 57982000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 41637000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Interest Income: -13148000.00
CVSA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
CVSA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -833000.00
CVSA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -833000.00
CVSA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -13148000.00
CVSA cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -7885000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Net PPE: 478051000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -354216000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 0.00
CVSA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 58731000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
CVSA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 58731000.00
CVSA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 111913000.00
CVSA income_statement (quarterly, 2026-03-31) — Normalized Income: 58809328.00
CVSA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 186166000.00
CVSA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 850000.00
CVSA income_statement (quarterly, 2026-03-31) — Operating Income: 92205000.00
CVSA income_statement (quarterly, 2026-03-31) — Operating Revenue: 484598000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 34023000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 78992000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3825000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2227000.00
CVSA income_statement (quarterly, 2026-03-31) — Other Gand A: 184106000.00
CVSA income_statement (quarterly, 2026-03-31) — Other Income Expense: -1112000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 757059000.00
CVSA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 4407000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 137300000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 36905000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Other Properties: 201079000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Payables: 97261000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 265200000.00
CVSA income_statement (quarterly, 2026-03-31) — Pretax Income: 77945000.00
CVSA cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 490000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CVSA cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 17422000.00
CVSA cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
CVSA cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -209000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Receivables: 175924000.00
CVSA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 210719000.00
CVSA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 20775000.00
CVSA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -618283000.00
CVSA cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -67504000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 1862000.00
CVSA income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 863000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2957419000.00
CVSA cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 209000.00
CVSA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 184106000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Share Issued: 84743000.00
CVSA income_statement (quarterly, 2026-03-31) — Special Income Charges: -863000.00
CVSA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 9571000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1364105000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -354216000.00
CVSA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -284672.00
CVSA income_statement (quarterly, 2026-03-31) — Tax Provision: 19963000.00
CVSA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
CVSA balance_sheet (quarterly, 2026-03-31) — Total Assets: 2737427000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1859749000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Total Debt: 736294000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1364105000.00
CVSA income_statement (quarterly, 2026-03-31) — Total Expenses: 394825000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1373322000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2333672000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 792875000.00
CVSA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 91342000.00
CVSA income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 1548000.00
CVSA income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1112000.00
CVSA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1112000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 50720000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 2288402000.00
CVSA balance_sheet (quarterly, 2026-03-31) — Working Capital: -176692000.00
CVSG.L income_statement (annual, 2021-06-30) — +Operating Expense: 181800000.00
CVSG.L income_statement (annual, 2021-06-30) — +Total Revenue: 510100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Accounts Payable: 40300000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Accounts Receivable: 27000000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -94200000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Additional Paid In Capital: 103700000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Allowance For Doubtful Accounts Receivable: -6400000.00
CVSG.L cash_flow (annual, 2021-06-30) — Amortization Cash Flow: 23800000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Available For Sale Securities: 100000.00
CVSG.L income_statement (annual, 2021-06-30) — Basic Average Shares: 70685939.00
CVSG.L income_statement (annual, 2021-06-30) — Basic EPS: 0.27
CVSG.L cash_flow (annual, 2021-06-30) — Beginning Cash Position: 21500000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Buildings And Improvements: 157900000.00
CVSG.L cash_flow (annual, 2021-06-30) — Capital Expenditure: -16600000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 98800000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Capital Stock: 100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 33700000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 33700000.00
CVSG.L cash_flow (annual, 2021-06-30) — Change In Inventory: -400000.00
CVSG.L cash_flow (annual, 2021-06-30) — Change In Payable: -5200000.00
CVSG.L cash_flow (annual, 2021-06-30) — Change In Receivables: -3400000.00
CVSG.L cash_flow (annual, 2021-06-30) — Change In Working Capital: -10100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Changes In Cash: 12200000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Common Stock: 100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Common Stock Equity: 191100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Common Stock Issuance: 1500000.00
CVSG.L income_statement (annual, 2021-06-30) — Cost Of Revenue: 288200000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Current Assets: 101400000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 8600000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 8600000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Current Liabilities: 98500000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Current Provisions: 3900000.00
CVSG.L cash_flow (annual, 2021-06-30) — Deferred Tax: 13800000.00
CVSG.L cash_flow (annual, 2021-06-30) — Depreciation: 24300000.00
CVSG.L cash_flow (annual, 2021-06-30) — Depreciation And Amortization: 48100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Derivative Product Liabilities: 400000.00
CVSG.L income_statement (annual, 2021-06-30) — Diluted Average Shares: 71169779.00
CVSG.L income_statement (annual, 2021-06-30) — Diluted EPS: 0.27
CVSG.L income_statement (annual, 2021-06-30) — Diluted NI Availto Com Stockholders: 19300000.00
CVSG.L income_statement (annual, 2021-06-30) — EBIT: 39700000.00
CVSG.L income_statement (annual, 2021-06-30) — EBITDA: 87800000.00
CVSG.L cash_flow (annual, 2021-06-30) — End Cash Position: 33700000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Financial Assets: 0.00
CVSG.L cash_flow (annual, 2021-06-30) — Financing Cash Flow: -12600000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Finished Goods: 19500000.00
CVSG.L cash_flow (annual, 2021-06-30) — Free Cash Flow: 43600000.00
CVSG.L cash_flow (annual, 2021-06-30) — Gain Loss On Sale Of PPE: 0.00
CVSG.L income_statement (annual, 2021-06-30) — General And Administrative Expense: 181800000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Goodwill: 113900000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Goodwill And Other Intangible Assets: 228400000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Gross Accounts Receivable: 33400000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Gross PPE: 248800000.00
CVSG.L income_statement (annual, 2021-06-30) — Gross Profit: 221900000.00
CVSG.L income_statement (annual, 2021-06-30) — Interest Expense: 6600000.00
CVSG.L income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 6600000.00
CVSG.L cash_flow (annual, 2021-06-30) — Interest Paid Cfo: -7100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Inventory: 19500000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Invested Capital: 275000000.00
CVSG.L cash_flow (annual, 2021-06-30) — Investing Cash Flow: -35400000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Investmentin Financial Assets: 100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 1500000.00
CVSG.L cash_flow (annual, 2021-06-30) — Issuance Of Debt: 0.00
CVSG.L balance_sheet (annual, 2021-06-30) — Land And Improvements: 19300000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 90200000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Long Term Debt: 83900000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 174100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Long Term Debt Issuance: 0.00
CVSG.L cash_flow (annual, 2021-06-30) — Long Term Debt Payments: -1100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 69900000.00
CVSG.L cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 1500000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Net Debt: 50200000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Income: 19300000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Income Common Stockholders: 19300000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Income Continuous Operations: 19300000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: 19300000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: 19300000.00
CVSG.L cash_flow (annual, 2021-06-30) — Net Income From Continuing Operations: 19300000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: 19300000.00
CVSG.L cash_flow (annual, 2021-06-30) — Net Intangibles Purchase And Sale: -500000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Interest Income: -7000000.00
CVSG.L cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: 0.00
CVSG.L cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: -1100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Net Long Term Debt Issuance: -1100000.00
CVSG.L income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -7000000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Net PPE: 154600000.00
CVSG.L cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -15500000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Net Tangible Assets: -37300000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Non Current Deferred Taxes Assets: 0.00
CVSG.L balance_sheet (annual, 2021-06-30) — Non Current Deferred Taxes Liabilities: 20400000.00
CVSG.L income_statement (annual, 2021-06-30) — Normalized EBITDA: 87800000.00
CVSG.L income_statement (annual, 2021-06-30) — Normalized Income: 19300000.00
CVSG.L cash_flow (annual, 2021-06-30) — Operating Cash Flow: 60200000.00
CVSG.L income_statement (annual, 2021-06-30) — Operating Income: 40100000.00
CVSG.L income_statement (annual, 2021-06-30) — Operating Revenue: 510100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 70753782.00
CVSG.L balance_sheet (annual, 2021-06-30) — Other Current Liabilities: -73500000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Other Intangible Assets: 114500000.00
CVSG.L cash_flow (annual, 2021-06-30) — Other Non Cash Items: 7000000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Other Non Current Liabilities: 488300000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Other Payable: 12700000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Other Properties: 1700000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Other Receivables: 12500000.00
CVSG.L income_statement (annual, 2021-06-30) — Otherunder Preferred Stock Dividend: 0.00
CVSG.L balance_sheet (annual, 2021-06-30) — Payables: 69900000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Prepaid Assets: 8600000.00
CVSG.L income_statement (annual, 2021-06-30) — Pretax Income: 33100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Properties: 0.00
CVSG.L cash_flow (annual, 2021-06-30) — Purchase Of Business: -19400000.00
CVSG.L cash_flow (annual, 2021-06-30) — Purchase Of Intangibles: -500000.00
CVSG.L cash_flow (annual, 2021-06-30) — Purchase Of Investment: 0.00
CVSG.L cash_flow (annual, 2021-06-30) — Purchase Of PPE: -16100000.00
CVSG.L income_statement (annual, 2021-06-30) — Reconciled Cost Of Revenue: 288200000.00
CVSG.L income_statement (annual, 2021-06-30) — Reconciled Depreciation: 48100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Repayment Of Debt: -1100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Retained Earnings: 149100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Sale Of Investment: 0.00
CVSG.L cash_flow (annual, 2021-06-30) — Sale Of PPE: 600000.00
CVSG.L income_statement (annual, 2021-06-30) — Selling General And Administration: 181800000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Share Issued: 70753782.00
CVSG.L cash_flow (annual, 2021-06-30) — Stock Based Compensation: 2200000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Stockholders Equity: 191100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Tangible Book Value: -37300000.00
CVSG.L income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
CVSG.L income_statement (annual, 2021-06-30) — Tax Provision: 13800000.00
CVSG.L income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.19
CVSG.L balance_sheet (annual, 2021-06-30) — Taxes Receivable: 100000.00
CVSG.L cash_flow (annual, 2021-06-30) — Taxes Refund Paid: -13000000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Assets: 484500000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Capitalization: 275000000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Debt: 182700000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 191100000.00
CVSG.L income_statement (annual, 2021-06-30) — Total Expenses: 470000000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 293400000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 383100000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 194900000.00
CVSG.L income_statement (annual, 2021-06-30) — Total Operating Income As Reported: 40100000.00
CVSG.L income_statement (annual, 2021-06-30) — Total Other Finance Cost: 400000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Total Tax Payable: 16900000.00
CVSG.L balance_sheet (annual, 2021-06-30) — Treasury Shares Number: 0.00
CVSG.L balance_sheet (annual, 2021-06-30) — Treasury Stock: 0.00
CVSG.L balance_sheet (annual, 2021-06-30) — Working Capital: 2900000.00
CVSG.L income_statement (annual, 2022-06-30) — +Operating Expense: 196300000.00
CVSG.L income_statement (annual, 2022-06-30) — +Total Revenue: 554200000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Accounts Payable: 40400000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Accounts Receivable: 27900000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -117400000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 106000000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -3900000.00
CVSG.L cash_flow (annual, 2022-06-30) — Amortization Cash Flow: 22200000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Available For Sale Securities: 100000.00
CVSG.L income_statement (annual, 2022-06-30) — Basic Average Shares: 70926977.00
CVSG.L income_statement (annual, 2022-06-30) — Basic EPS: 0.36
CVSG.L cash_flow (annual, 2022-06-30) — Beginning Cash Position: 33700000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Buildings And Improvements: 183700000.00
CVSG.L cash_flow (annual, 2022-06-30) — Capital Expenditure: -24500000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 104500000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Capital Stock: 100000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 49000000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 49000000.00
CVSG.L cash_flow (annual, 2022-06-30) — Cash Dividends Paid: -4600000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Cash Equivalents: 9000000.00
CVSG.L balance_sheet (annual, 2022-06-30) — Cash Financial: 40000000.00
CVSG.L cash_flow (annual, 2022-06-30) — Change In Inventory: -6600000.00